NHS Heart Checks: Age 25 Recommendation
- Manchester—Cardiovascular health experts at the British Cardiovascular Society Annual Conference 2025 emphasized the need for earlier cardiovascular risk assessments, shifting the focus to lifetime risk rather than just...
- Consultant cardiologist Derek Connolly expressed hope that England’s 10 Year Health Plan for the NHS would support this proactive approach.
- Recent data published in the European Journal of Preventative Cardiology projects a significant increase in the global cardiovascular disease (CVD) prevalence over the next 25 years.
Experts are now advocating for earlier cardiovascular health assessments, with a focus on lifetime risk, a significant shift likely to impact younger adults significantly. This proactive approach is driven by the rising burden of cardiovascular disease (CVD) and the potential for lifestyle interventions to save lives. Current NHS risk assessments,often starting at age 40,may overlook risks in younger populations. Consultant cardiologists suggest age 25 as a potential screening “sweet spot” to maximize cost-effective interventions and encourage lifestyle changes.News Directory 3 reports on this critical evolution in preventative cardiology, suggesting the potential for a targeted strategy focusing on those with family histories and elevated BMI. What innovative approaches will be implemented next to improve long-term heart health nationwide?
Early Cardiovascular Screening Urged for Lifetime Risk Assessment
Updated June 06, 2025
Manchester—Cardiovascular health experts at the British Cardiovascular Society Annual Conference 2025 emphasized the need for earlier cardiovascular risk assessments, shifting the focus to lifetime risk rather than just 10-year projections. Beverley bostock,president-elect of the Primary Care Cardiovascular Society (PCCS),introduced the session,highlighting that current assessments often occur too late.
Consultant cardiologist Derek Connolly expressed hope that England’s 10 Year Health Plan for the NHS would support this proactive approach. He noted the plan’s strong emphasis on preventive cardiology,citing potential benefits of lifestyle interventions in saving lives,reducing costs,and maintaining workforce productivity.
Recent data published in the European Journal of Preventative Cardiology projects a significant increase in the global cardiovascular disease (CVD) prevalence over the next 25 years. CVD-related deaths are expected to rise dramatically, underscoring the urgency of early intervention and effective CV risk management.
Jim Moore, a retired GP, pointed out that current NHS assessments, wich begin at age 40 and repeat every five years, may underestimate risk in younger individuals. He advocated for lifetime calculators as persuasive tools to encourage lifestyle changes and risk factor modifications.Moore stressed the importance of a holistic approach, which he finds lacking in primary care settings.
Scott Murray,a consultant cardiologist,argued for assessing cardiovascular risk in people under 40,citing modern lifestyles as contributors to rising CVD in younger populations. He suggested age 25 as a potential “sweet spot” for screening, aligning with a lifestyle transition into independent adulthood. Murray believes that starting CVD screening at this age would be cost-effective, maximizing opportunities for lower-cost interventions.
Laura Ormesher, a lecturer at the University of Manchester, proposed pregnancy as an opportune time to educate younger women about lifestyle-related CVD risk.She noted that adverse pregnancy outcomes increase the risk of cardiovascular disease, and the postnatal period offers a chance for women to improve their long-term health.
Lifestyle physician Sundhya Raman supported a targeted strategy, focusing on higher-risk individuals with strong family histories and elevated BMI. She emphasized the potential for educating families and communities through individual interventions.
“CVD risk is predicated around a lifetime exposure to risk factors. Just modest changes in those risk factors — your lipid profile or blood pressure — can, we certainly know independently, and in combination, improve your outcomes.”
What’s next
the medical community anticipates further discussions and potential policy changes to incorporate earlier and more complete cardiovascular risk assessments, aiming to reduce the long-term burden of CVD.